前收市價 | 11.11 |
開市 | 11.11 |
買盤 | 7.40 |
賣出價 | 8.40 |
拍板 | 175.00 |
到期日 | 2025-12-19 |
今日波幅 | 11.11 - 11.11 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 7 |
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared with treatment with Comirnaty.
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated version of mRNA COVID-19 jab, Comirnaty.
Recently BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry upside down.